ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,272
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Mo1412 Comparison Between Ulinastatin and Nafamostat Mesylate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Author(s):
Yoshiaki Kawaguchi
,
Tetsuya Mine
Publication date
Created:
May 2015
Publication date
(Print):
May 2015
Journal:
Gastrointestinal Endoscopy
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Tobacco Prevention & Cessation
Author and article information
Journal
Title:
Gastrointestinal Endoscopy
Abbreviated Title:
Gastrointestinal Endoscopy
Publisher:
Elsevier BV
ISSN (Print):
00165107
Publication date Created:
May 2015
Publication date (Print):
May 2015
Volume
: 81
Issue
: 5
Page
: AB411
Article
DOI:
10.1016/j.gie.2015.03.740
SO-VID:
1113f436-6510-4cbc-a6f8-977a9bc3c672
Copyright ©
© 2015
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,272
Nafamostat as Anticoagulant for Membrane Plasmapheresis in high Bleeding risk Patients
Authors:
E Kinugasa
,
T. AKIZAWA
,
Y. NAKASHIMA
…
Identification of an Existing Japanese Pancreatitis Drug, Nafamostat, which is Expected to Prevent the Transmission of New Coronavirus Infection (COVID-19)
Authors:
J Inoue
,
M. YAMAMOTO
,
J. INOUE
…
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
Authors:
S. Lange
See all similar